missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SARS-CoV-2 Nucleocapsid (strain Wuhan-Hu-1) Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5143459
This item is not returnable.
View return policy
Description
Store as concentrated solution. Centrifuge briefly prior to opening vial.
SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. The SARS-CoV-2 N protein is an abundant RNA-binding protein critical for viral genome packaging, yet the molecular details that involve this process are poorly understood. N protein contains three dynamic disordered regions that house putative transiently-helical binding motifs. The two folded domains interact minimally such that full-length N protein is a flexible and multivalent RNA-binding protein. SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.
Specifications
| SARS-CoV-2 Nucleocapsid (strain Wuhan-Hu-1) | |
| Polyclonal | |
| Unconjugated | |
| N | |
| COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid; SARS-CoV-2 N | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 43740575 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 20% glycerol and 0.025% Proclin 300; pH 7 | |
| P0DTC9 | |
| N | |
| Recombinant protein encompassing a sequence within the C-terminus region of SARS-CoV-2 (COVID-19) nucleocapsid (SARS-CoV-2 (strain Wuhan-Hu-1)). The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Virus | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction